The Effect of Topical Gentamicin and Mupirocin on Peritonitis and Exit Site Infection in Peritoneal Dialysis Patients

Document Type : Original Article(s)

Authors

1 Isfahan Kidney Diseases Research Center, Assistant Professor, Department of Nephrology, School of Medicine ,Isfahan University of Medical Sciences, Isfahan, Iran.

2 Nephrology Resident, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

3 Isfahan Kidney Diseases Research Center, Associate Professor, Department of Nephrology, School of Medicine ,Isfahan University of Medical Sciences, Isfahan, Iran.

4 Associate Professor, Department of Social Medicine, School of Medicine ,Isfahan University of Medical Sciences, Isfahan, Iran.

5 Internal Medicine Resident, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

6 Nurse, Peritoneal Dialysis, Alzahra Hospital, Isfahan, Iran.

Abstract

Background: Peritonitis is the most important complication of peritoneal dialysis. The most common cause of peritonitis is catheter exit site infection. Several studies have shown the prophylactic effect of topical mupirocin. According to the report of drug resistance in several studies to muprocin and exit site infection with gram-negative organisms, this study compared the prophylacyic effect of gentamicin with muprocin.Methods: This double blind clinical trial was done on 121 peritoneal dialysis patients. We have investigated the frequency of peritonitis and exit site infection in 2 groups receiving gentamicin and mupirocin ointment for 6 months. Data were analyzed by SPSS software using Student-t, chi-square and logistic regression tests.Finding: After six months, 8 cases of peritonitis were reported in gentamicin group compared to no cases in mupirocin group (P = 0.03). The exit site infection in the fourth and fifth months in the gentamicin group compared to mupirocin group was respectively 4.2 and 3.3 times (P = 0.0001).Conclusion: According to the results of this study, gentamicin ointment have not shown a prophylactic effect on the incidence of exit site infection and peritonitis compared with mupirocin ointment and it is not recommended as a substitute.

Keywords

References

  1. Golper TA, Brier ME, Bunke M, Schreiber MJ, Bartlett DK, Hamilton RW, et al. Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies. Am J Kidney Dis 1996; 28(3): 428-36.
  2. Fried L, Abidi S, Bernardini J, Johnston JR, Piraino B. Hospitalization in peritoneal dialysis patients. Am J Kidney Dis 1999; 33(5): 927-33.
  3. Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7(10): 2176-82.
  4. Flanigan M, Gokal R. Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments. Perit Dial Int 2005; 25(2): 132-9.
  5. Piraino B, Bernardini J, Florio T, Fried L. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit Dial Int 2003; 23(5): 456-9.
  6. Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005; 16(2): 539-45.
  7. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006; (103): S55-S62.
  8. Prasad N, Gupta A, Mathew M, Abraham G. Access-related complications in peritoneal dialysis in developing countries. Adv Ren Replace Ther 2002; 9(2): 144-8.
  9. Annigeri R, Conly J, Vas S, Dedier H, Prakashan KP, Bargman JM, et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001; 21(6): 554-9.
  10. Lobbedez T, Gardam M, Dedier H, Burdzy D, Chu M, Izatt S, et al. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant 2004; 19(12): 3140-3.
  11. Chu KH, Choy WY, Cheung CC, Fung KS, Tang HL, Lee W, et al. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections. Perit Dial Int 2008; 28(5): 505-8.
Journal of Isfahan Medical School
Volume 28, Issue 116 - Serial Number 116
September and October 2011
Pages 1062-1069

Files

History

  • Receive Date: 07 March 2011
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics